Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.36%23.67B | 13.30%6.55B | 15.52%6.49B | 10.81%5.59B | 13.62%5.03B | 22.30%20.88B | 30.96%5.78B | 26.03%5.62B | 19.30%5.05B | 11.68%4.43B |
Operating revenue | 13.36%23.67B | 13.30%6.55B | 15.52%6.49B | 10.81%5.59B | 13.62%5.03B | 22.30%20.88B | 30.96%5.78B | 26.03%5.62B | 19.30%5.05B | 11.68%4.43B |
Cost of revenue | 12.35%20.16B | 9.99%5.49B | 14.81%5.48B | 10.60%4.78B | 14.33%4.41B | 23.38%17.95B | 33.14%4.99B | 26.59%4.77B | 19.88%4.32B | 12.83%3.86B |
Gross profit | 19.53%3.51B | 34.18%1.06B | 19.50%1.01B | 12.05%811.33M | 8.78%623.49M | 16.13%2.94B | 18.71%792.47M | 23.01%847.32M | 15.93%724.1M | 4.56%573.2M |
Operating expense | 19.71%2.21B | 30.92%621.99M | 29.79%594.3M | 12.63%511.57M | 5.01%479.85M | 9.08%1.84B | 17.52%475.1M | 10.44%457.9M | 5.34%454.2M | 3.70%456.96M |
Selling and administrative expenses | 17.34%1.82B | 26.58%506.18M | 25.18%483.88M | 12.54%432.36M | 4.63%402.34M | 16.34%1.56B | 17.22%399.88M | 11.25%386.54M | 18.85%384.17M | 18.36%384.55M |
Depreciation amortization depletion | 32.51%382.96M | 53.95%115.81M | 54.74%110.42M | 13.12%79.21M | 7.05%77.51M | -18.35%289.01M | 19.16%75.23M | 6.28%71.36M | -35.13%70.03M | -37.45%72.4M |
-Depreciation and amortization | 32.51%382.96M | 53.95%115.81M | 54.74%110.42M | 13.12%79.21M | 7.05%77.51M | -18.35%289.01M | 19.16%75.23M | 6.28%71.36M | -35.13%70.03M | -37.45%72.4M |
Operating profit | 19.22%1.3B | 39.07%441.37M | 7.41%418.27M | 11.06%299.76M | 23.57%143.64M | 30.35%1.09B | 20.53%317.37M | 42.00%389.43M | 39.56%269.9M | 8.10%116.24M |
Net non-operating interest income expense | 3.29%-170.28M | 1.99%-42.76M | -15.76%-52.71M | 10.65%-41.76M | 17.74%-33.05M | -44.62%-176.08M | -22.72%-43.63M | -37.45%-45.54M | -64.48%-46.74M | -62.93%-40.18M |
Non-operating interest income | 199.21%32.4M | 131.35%13.59M | 263.12%7.24M | 145.65%3.56M | 429.22%8.02M | 315.58%10.83M | 212.56%5.87M | 357.11%1.99M | 552.25%1.45M | 2,097.10%1.52M |
Non-operating interest expense | 8.44%202.69M | 13.83%56.34M | 26.13%59.95M | -5.95%45.32M | -1.49%41.07M | 50.30%186.91M | 32.25%49.5M | 41.60%47.53M | 68.26%48.19M | 68.61%41.69M |
Other net income (expense) | 49.26%79.27M | 12.97%17.7M | 121.86%15.89M | -28.95%9.09M | 109.27%36.59M | 513.97%53.1M | -12.62%15.67M | 160.18%7.16M | 146.39%12.79M | 100.76%17.49M |
Earnings from equity interest | 21.33%50.48M | 42.49%15.55M | 19.71%14.02M | -8.37%8.59M | 28.21%12.33M | -20.69%41.61M | 34.45%10.91M | 10.10%11.71M | -49.53%9.37M | -36.51%9.62M |
Special income (charges) | -7.55%-7.06M | 27.15%-4.2M | -39.98%-1.12M | ---1.12M | ---623K | 65.21%-6.57M | 52.06%-5.77M | -141.74%-803K | --0 | --0 |
-Less:Restructuring and merger&acquisition | 7.55%7.06M | -27.15%4.2M | 39.98%1.12M | --1.12M | --623K | 48.53%6.57M | 1,466.58%5.77M | 141.74%803K | --0 | --0 |
-Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 98.44%35.85M | -39.63%6.35M | 179.97%2.99M | -52.71%1.62M | 216.32%24.88M | 138.92%18.06M | -51.82%10.52M | 84.69%-3.74M | 108.04%3.42M | 717.91%7.87M |
Income before tax | 24.96%1.21B | 43.85%416.32M | 8.66%381.44M | 13.19%267.08M | 57.34%147.19M | 37.80%969.96M | 17.80%289.41M | 53.16%351.05M | 71.71%235.95M | 2.15%93.55M |
Income tax | 29.86%284.75M | 39.88%106.03M | 6.32%82.42M | 8.41%75.2M | 716.66%21.1M | 14.06%219.27M | 5.95%75.8M | 6.35%77.52M | 68.15%69.37M | -152.18%-3.42M |
Net income | 23.52%927.28M | 45.26%310.29M | 9.32%299.02M | 15.19%191.88M | 30.03%126.09M | 46.72%750.69M | 22.67%213.61M | 74.98%273.53M | 73.24%166.58M | 14.04%96.97M |
Net income continuous Operations | 23.52%927.28M | 45.26%310.29M | 9.32%299.02M | 15.19%191.88M | 30.03%126.09M | 46.72%750.69M | 22.67%213.61M | 74.98%273.53M | 73.24%166.58M | 14.04%96.97M |
Minority interest income | 274.32%22.46M | 91.23%5.17M | 747.02%5.84M | 443.80%3.73M | 301.82%7.73M | -70.67%6M | -76.64%2.7M | 91.39%689K | -91.58%685K | 397.16%1.92M |
Net income attributable to the parent company | 21.50%904.82M | 44.67%305.12M | 7.46%293.19M | 13.42%188.16M | 24.53%118.36M | 51.61%744.69M | 29.73%210.91M | 74.94%272.84M | 88.48%165.9M | 12.29%95.05M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 21.50%904.82M | 44.67%305.12M | 7.46%293.19M | 13.42%188.16M | 24.53%118.36M | 51.61%744.69M | 29.73%210.91M | 74.94%272.84M | 88.48%165.9M | 12.29%95.05M |
Basic earnings per share | 20.08%6.16 | 42.07%2.06 | 5.85%1.99 | 12.28%1.28 | 22.73%0.81 | 50.00%5.13 | 27.19%1.45 | 72.48%1.88 | 86.89%1.14 | 11.86%0.66 |
Diluted earnings per share | 20.60%6.03 | 42.96%2.03 | 6.56%1.95 | 12.50%1.26 | 23.44%0.79 | 50.60%5 | 29.09%1.42 | 72.64%1.83 | 89.83%1.12 | 12.28%0.64 |
Dividend per share | 12.12%0.37 | 11.11%0.1 | 12.50%0.09 | 12.50%0.09 | 12.50%0.09 | 13.79%0.33 | 12.50%0.09 | 14.29%0.08 | 14.29%0.08 | 14.29%0.08 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |